Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialLennart Hansson, S. Westerling, Alberto Zanchetti et al.|The Lancet|1998Cited by 5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololBjörn Dahlöf, Hans Wedel, Richard B. Devereux et al.|The Lancet|2002Cited by 5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese SubjectsLars Sjöström, Lena Carlsson, Kristina Narbro et al.|New England Journal of Medicine|2007Cited by 4.6k
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric SurgeryLars Sjöström, Hans Wedel, Kristina Narbro et al.|New England Journal of Medicine|2004Cited by 4.5k
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter Sever, Jan Östergren, Björn Dahlöf et al.|The Lancet|2003Cited by 3.8k